September 30, 2026
Pricing Malpractice Risk Before the Claim
Risk managers price exposure across a whole book of claims, not one case at a time, and malpractice data reads differently at that scale. The most expensive cases are often the ones your review process pays least attention to. Here is where portfolio-level exposure actually hides.
Category: Case Strategy|Reading time: ~5 min
A defense attorney manages one case to the best outcome available. A risk manager sets the assumptions behind hundreds of them. That difference matters more than it looks. When a defense attorney misjudges a case, the cost is one bad result. When a risk manager carries a flawed assumption across a book of claims, the cost compounds.
Most malpractice analysis is written for the single case. Read at portfolio scale, the same data reprices several things a risk program tends to take for granted. Here is where the exposure sits.
Reserving against a number that has not finished moving
Malpractice severity has been rising, and recent-year data understates how much. Because claims take years to resolve, recent accident years show only the early, pre-resolution slice of a population that keeps climbing as cases mature. As S&P Global Market Intelligence has noted, the apparent calm in the newest numbers is an artifact of timing, not a real softening.
For a single claim, that means a reserve set a bit low. For a program, it means a reserve pool, a budget line, and a board report all built on the same lagging benchmark. A captive funded, or a self-insured retention set, against recent accident-year severity is funded to a number that has not stopped moving. This is a portfolio problem wearing a single-claim disguise.
Aggregate tail risk is not the sum of the medians
A book of claims that each look modest at the median can carry a combined tail that the medians hide completely. Add up the midpoints and the total looks manageable. But exposure does not resolve at the midpoint; a handful of claims land far out on the right, and at portfolio scale those are the events that breach a retention or blow through a layer.
This is the analysis that should inform excess attachment points and retention decisions, and it is rarely the analysis that gets run. The median tells you what a typical claim costs. It tells you nothing about the year a few of them cost everything.
One reserving standard is wrong at every facility that differs
Multi-site systems span counties and, often, state lines. Jurisdiction is the strongest single driver of malpractice outcomes, so a single internal reserving standard applied across all of them is wrong in opposite directions at once.
The gap is not subtle. A comparable case carries a median payout near $73,000 in California and near $507,000 in Pennsylvania. The same clinical event carries very different financial exposure at two hospitals under the same logo. A central standard over-reserves the capped sites and under-reserves the rest, which means it is inaccurate nearly everywhere. Venue belongs in facility-level risk reporting, and in the diligence when a system acquires in a new jurisdiction.
The cases your review process watches least cost the most
This is the finding with the most direct patient-safety implication, and it is the one most likely to be pointed the wrong way.
Mortality review is institutionalized. A death triggers a morbidity and mortality conference, root-cause analysis, and formal review pathways. Severe-injury survivals often receive none of that scrutiny. Yet the data runs against the instinct: cases that end in grave permanent injury carry a higher median payout than cases that end in death, roughly $807,000 against $311,000. Ongoing care, lost earning capacity, and a plaintiff who can testify to their own suffering push survival cases above wrongful-death claims.
If your review triggers are calibrated to mortality, they are calibrated away from your largest financial exposure. The catastrophic survival, not the death, is the case most likely to be under-reserved and least likely to have been reviewed.
Prior history is a credentialing input, not just a claims input
Practitioners with five or more prior adverse reports settle for about 43 percent more than first-time reporters. That is a quantified multiplier, and it is one of the few risk signals a system can act on years before any claim exists.
Prior history is already collected during credentialing and ongoing professional practice evaluation. It tends to be weighed qualitatively, as a concern, rather than priced as a risk. Yet it is precisely a credentialing decision, made long before an incident, that measurably changes what an eventual claim costs. Pricing it there, not just at the claims desk, is where a risk program has leverage the claims desk never gets.
The through-line
Everything above points the same direction. A risk manager's real leverage is upstream of the claim, and the data shows where it concentrates: high-severity survival events, prior-history practitioners, and service lines whose exposure profile does not match their claim frequency. A defense attorney inherits the case. A risk manager can change which cases arrive, and how well funded the program is when they do.
Try It
Run the case profiles that recur across your organization, by service line, facility, and injury severity, and read where the exposure concentrates rather than what any single claim is worth. That map is far easier to take to a board than last year's largest verdict.
MedMalPredict AI is not legal advice. Predictions are based on historical data and represent probabilities, not guarantees.
Enjoyed this article?
Subscribe to get insights on medical malpractice trends, AI in litigation, and data-backed case analysis. No spam, unsubscribe anytime.